Insulet Inc. (PODD) Long-Term Liabilities to Equity

Corporate emblem and logo of Insulet Inc. (PODD)

The visualization of the Insulet Corporation (PODD) market price on the GURU.Markets platform, where the indicator stands at 0.68, reflects the price action of the wireless diabetes system manufacturer. Insulet Corporation is implementing innovative pumps with glucose sensors to drive global expansion. High user loyalty to consumables transforms the business model into a stable cash cow. Despite concerns regarding weight-loss drugs, the unique design protects the business from competitors.

PODD OmniPod: Long-Term Debt to Capital in the range 07/04/2022 - 10/30/2026
Manufactured product of Insulet Corporation

This ratio determines the degree of financial autonomy by comparing long-term liabilities against equity to assess long-term solvency. By analyzing the current long-term debt-to-equity ratio, an investor can gauge the financing efficiency of Insulet Corporation (PODD) as it expands production capacities in the US and Europe, which is critical for ensuring the seamless logistics of medical components.

Key competitors

Boston Scientific Corp (BSX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Edwards Lifesciences Corp (EW)|RMD: Long-Term Liabilities to Equity|Long-Term Debt to Capital ZBH (Zimmer Biomet Corp)|coopercos.com (COO) - Long-Term Liabilities to Capital|Align Technology - Long-Term Debt to Capital|Globus Medical Inc (GMED) - Long-Term Debt to Equity Ratio|TMDX: Long-Term Debt to Capital|ATEC - Ratio of Long-Term Indebtedness to Capital|AORT (Artivion, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital enovis.com|Long-Term Debt to Equity Integra LifeSciences Holdings Corporation (IART)|Long-Term Debt to Equity ESTA (Establishment Labs Corp)|Long-Term Debt to Capital BBNX (Beta Bionics Corp)|Ratio of Long-Term Indebtedness to Capital IRADIMED Inc. (IRMD)|EMBC: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity TNDM|AXGN: Long-Term Debt to Capital|Long-Term Liabilities to Capital SI-BONE Inc (SIBN)|OFIX (Orthofix International) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio BVS (Bioventus Global)|Long-Term Debt to Equity Ratio KIDS (OrthoPediatrics Corp.)|TMCI (treace.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Strata Critical Medical SRTA|CARL - Long-Term Debt to Equity Ratio|RxSight Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital ClearPoint Neuro, Inc.|STXS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio STIM|SGHT (Sight Sciences) - Long-Term Debt to Capital|Orchestra BioMed Inc. (OBIO) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ANIK|Long-Term Debt to Equity Ratio InspireMD Inc. NSPR|Long-Term Debt to Capital ZJYL (Jin Medical)|Long-Term Debt to Capital Vivani Medical Inc VANI|XTNT - Long-Term Debt to Equity|NMTC: Long-Term Debt to Equity|MODD (modular-medical.com) - Long-Term Debt to Equity Ratio|Myomo Inc - Long-Term Debt to Capital Coefficient|COCH (Envoy Medical, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital vivoslife.com VVOS|Long-Term Debt to Equity enVVeno Medical Corp. (NVNO)|sintx.com (SINT) - Long-Term Indebtedness to Equity|Tenon Medical, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Lifeward Ltd. LFWD|Autonomix - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital invobioscience.com IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Liabilities to Equity AXNX (Axonics Inc.)|Long-Term Debt to Equity Biolase, Inc.|Long-Term Debt to Equity Ratio Dynatronics Corp. (DYNT)|Long-Term Debt to Capital FNA|INVO - Long-Term Liabilities to Capital